Vyalev

Active Ingredient(s): Foscarbidopa + Foslevodopa
FDA Approved: * October 16, 2024
Pharm Company: * ABBVIE
Category: Parkinsons
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vyalev Subcutaneous Injection
NDC: 0074-0501
Labeler:
Abbvie Inc.